{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:09:55Z","timestamp":1778594995091,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004048","name":"Kashan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03125-1","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:04:09Z","timestamp":1763438649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combined Inhibition of telomerase and mitochondria synergistically promote apoptosis in AML cell lines"],"prefix":"10.1007","volume":"43","author":[{"given":"Hossein","family":"Kalarestaghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadijeh","family":"Dizaji Asl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Mazloumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Hemmati-Dinarvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Ghotaslou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Nejati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Rafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"3125_CR1","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1186624","volume":"327","author":"Y Wang","year":"2010","unstructured":"Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, et al. The Wnt\/\u03b2-catenin pathway is required for the development of leukemia stem cells in AML. Science. 2010;327:1650.","journal-title":"Science"},{"key":"3125_CR2","unstructured":"Fergany A, Hassanein KM, Abdel Hameed MR, Kamel AM, Zahran AM. CD34+CD38-stem cells and CD34+CD38+progenitor cells as markers of chemotherapy response in acute myeloid leukemia patients. Immunopathologia Persa. 2025;11(2):e43799."},{"key":"3125_CR3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345.","journal-title":"Blood"},{"key":"3125_CR4","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1011","volume":"10","author":"NJ Short","year":"2020","unstructured":"Short NJ, Konopleva M, Kadia TM, Borthakur G, Ravandi F, DiNardo CD, et al. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges. Cancer Discov. 2020;10:506.","journal-title":"Cancer Discov"},{"key":"3125_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645.","journal-title":"Nature"},{"key":"3125_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ccell.2015.03.009","volume":"27","author":"AH Shih","year":"2015","unstructured":"Shih AH, Jiang Y, Meydan C, Shank K, Pandey S. Barreyro let al.: mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia. Cancer Cell. 2015;27:502.","journal-title":"Cancer Cell"},{"key":"3125_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730.","journal-title":"Nat Med"},{"key":"3125_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.015","volume":"20","author":"M \u0160krti\u0107","year":"2011","unstructured":"\u0160krti\u0107 M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell. 2011;20:674.","journal-title":"Cancer Cell"},{"key":"3125_CR9","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1111\/bph.14494","volume":"175","author":"J Garrido-Mesa","year":"2018","unstructured":"Garrido-Mesa J, Rodr\u00edguez\u2010Nogales A, Algieri F, Vezza T, Hidalgo\u2010Garcia L. Garrido\u2010Barros Met al.: Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution. Br J Pharmacol. 2018;175:4353.","journal-title":"Br J Pharmacol"},{"key":"3125_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0304-3835(84)80023-3","volume":"25","author":"AM Kroon","year":"1984","unstructured":"Kroon AM, Dontje BH, Holtrop M, Van Den Bogert C. The mitochondrial genetic system as a target for chemotherapy: tetracyclines as cytostatics. Cancer Lett. 1984;25:33.","journal-title":"Cancer Lett"},{"key":"3125_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200311000-00001","volume":"14","author":"Z Saikali","year":"2003","unstructured":"Saikali Z, Singh G. Doxycycline and other tetracyclines in the treatment of bone metastasis. Anticancer Drugs. 2003;14:773.","journal-title":"Anticancer Drugs"},{"key":"3125_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03756-z","volume":"39","author":"KS Kechagias","year":"2020","unstructured":"Kechagias KS, Chorepsima S, Triarides NA, Falagas ME. Tigecycline for the treatment of patients with clostridium difficile infection: an update of the clinical evidence. Eur J Clin Microbiol Infect Dis. 2020;39:1053.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3125_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/24.6.1100","volume":"24","author":"PP Wang","year":"1995","unstructured":"Wang PP, Haines CS. Childhood and adolescent leukaemia in a North American population. Int J Epidemiol. 1995;24:1100.","journal-title":"Int J Epidemiol"},{"key":"3125_CR14","volume":"69","author":"H Brincker","year":"1985","unstructured":"Brincker H. Estimate of overall treatment results in acute nonlymphocytic leukemia based on age-specific rates of incidence and of complete remission. Cancer Treat Rep. 1985;69:5.","journal-title":"Cancer Treat Rep"},{"key":"3125_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2573-2","volume":"74","author":"N Lipinska","year":"2017","unstructured":"Lipinska N, Romaniuk A, Paszel-Jaworska A, Toton E, Kopczynski P, Rubis B. Telomerase and drug resistance in cancer. Cell Mol Life Sci. 2017;74:4121.","journal-title":"Cell Mol Life Sci"},{"key":"3125_CR16","volume":"10","author":"AS Abdulrahman","year":"2025","unstructured":"Abdulrahman AS, Rasul KH, Mustafa IA, Abdulqadir SZ. In vitro anti-cancer potentiality of quince and dandelion leaves extract against leukemia cell lines and database retrieval expression of BCR ABL and TCR genes in leukemia. Immunopathol Persa. 2025;10:e41730.","journal-title":"Immunopathol Persa"},{"key":"3125_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/350569a0","volume":"350","author":"EH Blackburn","year":"1991","unstructured":"Blackburn EH. Structure and function of telomeres. Nature. 1991;350:569.","journal-title":"Nature"},{"key":"3125_CR18","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","volume":"266","author":"N Kim","year":"1994","unstructured":"Kim N. Piatyszek. MA, Prowse, KR, Harley, CB, West, M. D., Ho, PL, Coviello, GM, Wright, WE, Weinrich, SL, and Shay, JW specific association of human telomerase activity with immortal cells and cancer. Science(Washington DC). 1994;266:2011.","journal-title":"Science(Washington DC)"},{"key":"3125_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nature08137","volume":"460","author":"JI Park","year":"2009","unstructured":"Park JI, Venteicher AS, Hong JY, Choi J, Jun S, et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009;460:66.","journal-title":"Nature"},{"key":"3125_CR20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3892\/or_00000802","volume":"23","author":"RG Zhang","year":"2010","unstructured":"Zhang RG, Zhao JJ, Yang LQ, Yang SM, Wang RQ. Chen WSet al.: RNA interference-mediated hTERT Inhibition enhances TRAIL-induced apoptosis in resistant hepatocellular carcinoma cells. Oncol Rep. 2010;23:1013.","journal-title":"Oncol Rep"},{"key":"3125_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrc2275","volume":"8","author":"CB Harley","year":"2008","unstructured":"Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer. 2008;8:167.","journal-title":"Nat Rev Cancer"},{"key":"3125_CR22","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1158\/1535-7163.MCT-06-0033","volume":"5","author":"MA Cerone","year":"2006","unstructured":"Cerone MA, Londo\u00f1o-Vallejo JA, Autexier C. Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther. 2006;5:1669.","journal-title":"Mol Cancer Ther"},{"key":"3125_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11523-015-0364-y","volume":"10","author":"Y Shi","year":"2015","unstructured":"Shi Y, Sun L, Chen G, Zheng D, Li L, Wei W. A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines. Target Oncol. 2015;10:565.","journal-title":"Target Oncol"},{"key":"3125_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cbf.3687","volume":"40","author":"A Rafat","year":"2022","unstructured":"Rafat A, Dizaji Asl K, Mazloumi Z, Movassaghpour AA, Farahzadi R. Nejati bet al.: Telomerase-based therapies in haematological malignancies. Cell Biochem Funct. 2022;40:127.","journal-title":"Cell Biochem Funct"},{"key":"3125_CR25","doi-asserted-by":"publisher","first-page":"120402","DOI":"10.1016\/j.lfs.2022.120402","volume":"295","author":"A Rafat","year":"2022","unstructured":"Rafat A, Asl KD, Mazloumi Z, Movassaghpour AA, Talebi M. Shanehbandi Det al.: telomerase Inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways. Life Sci. 2022;295:120402.","journal-title":"Life Sci"},{"key":"3125_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/ng.3781","volume":"49","author":"FP Barthel","year":"2017","unstructured":"Barthel FP, Wei W, Tang M, Martinez-Ledesma E, Hu X. Amin SBet al.: systematic analysis of telomere length and somatic alterations in 31 cancer types. Nat Genet. 2017;49:349.","journal-title":"Nat Genet"},{"key":"3125_CR27","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0062","volume":"6","author":"JW Shay","year":"2016","unstructured":"Shay JW. Role of telomeres and telomerase in aging and cancer. Cancer Discov. 2016;6:584.","journal-title":"Cancer Discov"},{"key":"3125_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38942","volume":"120","author":"I Samudio","year":"2010","unstructured":"Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest. 2010;120:142.","journal-title":"J Clin Invest"},{"key":"3125_CR29","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1002\/cam4.845","volume":"5","author":"GA Reed","year":"2016","unstructured":"Reed GA, Schiller GJ, Kambhampati S, Tallman MS, Douer D, et al. A phase 1 study of intravenous infusions of Tigecycline in patients with acute myeloid leukemia. Cancer Med. 2016;5:3031.","journal-title":"Cancer Med"},{"key":"3125_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118060","volume":"257","author":"A Nasrollahzadeh","year":"2020","unstructured":"Nasrollahzadeh A, Bashash D, Kabuli M, Zandi Z, Kashani B, et al. Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-\u03baB signaling pathway. Life Sci. 2020;257:118060.","journal-title":"Life Sci"},{"key":"3125_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbrc.2022.11.090","volume":"640","author":"Z Mazloumi","year":"2023","unstructured":"Mazloumi Z, Rafat A, Asl KD, Charoudeh HN. A combination of telomerase Inhibition and NK cell therapy increased breast cancer cell line apoptosis. Biochem Biophys Res Commun. 2023;640:50.","journal-title":"Biochem Biophys Res Commun"},{"key":"3125_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbrc.2014.02.043","volume":"446","author":"C Tang","year":"2014","unstructured":"Tang C, Yang L, Jiang X, Xu C, Wang M, Wang Q. Antibiotic drug Tigecycline inhibited cell proliferation and induced autophagy in gastric cancer cells. Biochem Biophys Res Commun. 2014;446:105.","journal-title":"Biochem Biophys Res Commun"},{"key":"3125_CR33","volume":"7","author":"X Fu","year":"2017","unstructured":"Fu X, Liu W, Huang Q, Wang Y, Li H, Xiong Y. Targeting mitochondrial respiration selectively sensitizes pediatric acute lymphoblastic leukemia cell lines and patient samples to standard chemotherapy. Am J Cancer Res. 2017;7:2395.","journal-title":"Am J Cancer Res"},{"key":"3125_CR34","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1182\/blood-2003-12-4322","volume":"105","author":"H El-Daly","year":"2005","unstructured":"El-Daly H, Kull M, Zimmermann S, Pantic M, Waller CF, Martens UM. Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. Blood. 2005;105:1742.","journal-title":"Blood"},{"key":"3125_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/07357907.2011.629378","volume":"30","author":"D Bashash","year":"2012","unstructured":"Bashash D, Ghaffari S, Zaker F, Hezave K, Kazerani M, Ghavamzadeh A. Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription. Cancer Invest. 2012;30:57.","journal-title":"Cancer Invest"},{"key":"3125_CR36","doi-asserted-by":"publisher","first-page":"e2562","DOI":"10.1038\/cddis.2016.425","volume":"7","author":"A Celeghin","year":"2016","unstructured":"Celeghin A, Giunco S, Freguja R, Zangrossi M, Nalio S. Dolcetti Ret al.: Short-term Inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells. Cell Death Dis. 2016;7:e2562.","journal-title":"Cell Death Dis"},{"key":"3125_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1910574116","volume":"116","author":"W Qian","year":"2019","unstructured":"Qian W, Kumar N, Roginskaya V, Fouquerel E, Opresko PL, Shiva S, et al. Chemoptogenetic damage to mitochondria causes rapid telomere dysfunction. Proc Natl Acad Sci U S A. 2019;116:18435.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03125-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03125-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03125-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:49:39Z","timestamp":1769485779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03125-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3125"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03125-1","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}